The Latest Health Care-Related Legislation

Check out the latest health care-related legislation introduced in the House and Senate.

Senate

S. 265, Jack Reed, to amend the Public Health Service Act to provide grants for community-based mental health infrastructure improvement.

S. 264, Debbie Stabenow, to expand access to community mental health centers and improve the quality of mental health care for all Americans.

S. 254, Robert Menendez, to amend title III of the Public Health Service Act to authorize and support the creation of cardiomyopathy education, awareness, and risk assessment materials and resources by the Secretary of Health and Human Services through the Centers for Disease Control and Prevention and the dissemination of such materials and resources by State educational agencies to identify more at-risk families.

S. 252, Lamar Alexander, to reduce preterm labor and delivery and the risk of pregnancy-related deaths and complications due to pregnancy, and to reduce infant mortality caused by prematurity.

S. 242, Richard Burr, to reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, and for other purposes.

S. 239, Lisa Murkowski, to extend the frontier extended stay clinic demonstration.

S. 237, Lisa Murkowski, to amend the Public Health Service Act to reauthorize and extend the Fetal Alcohol Syndrome prevention and services program, and for other purposes.

S. 236, Lisa Murkowski, to amend title XVIII of the Social Security Act to establish a Medicare payment option for patients and physicians or practitioners to freely contract, without penalty, for Medicare fee-for-service items and services, while allowing Medicare beneficiaries to use their Medicare benefits.

S. 232, Orrin Hatch (with 7 cosponsors), to amend the Internal Revenue Code of 1986 to repeal the excise tax on medical devices.

S. 214, Amy Klobuchar, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.

House

H.R. 582, Michael Turner, to amend the Internal Revenue Code of 1986 to repeal the individual and employer health insurance mandates.

H.R. 581, Michael Turner, to amend the Internal Revenue Code of 1986 to exempt certain emergency medical devices from the excise tax on medical devices, and for other purposes.

H.R. 574, Allyson Schwartz, to amend part B of title XVIII of the Social Security Act to reform Medicare payment for physicians’ services by eliminating the sustainable growth rate system and providing incentives for the adoption of innovative payment and delivery models to improve quality and efficiency.

H.R. 567, Todd Rokita (with 34 cosponsors), to amend the Social Security Act to replace the Medicaid program and the Children’s Health Insurance program with a block grant to the States, and for other purposes.

H.R. 565, Frank Pallone, to amend title III of the Public Health Service Act to authorize and support the creation of cardiomyopathy education, awareness, and risk assessment materials and resources by the Secretary of Health and Human Services through the Centers for Disease Control and Prevention and the dissemination of such materials and resources by State educational agencies to identify more at-risk families.

H.R. 564, Frank Pallone, to amend title V of the Social Security Act to extend funding for family-to-family health information centers to help families of children with disabilities or special health care needs make informed choices about health care for their children.

H.R. 544, Phil Gingrey (with 12 cosponsors), to amend title XXVII of the Public Health Service Act to change the permissible age variation in health insurance premium rates.

H.R. 541, Anna Eshoo, to reduce preterm labor and delivery and the risk of pregnancy-related deaths and complications due to pregnancy, and to reduce infant mortality caused by prematurity.

H.R. 523, Erik Paulsen (with 178 cosponsors), to amend the Internal Revenue Code of 1986 to repeal the excise tax on medical devices.

H.R. 505, Keith Ellison, to repeal sequester while achieving balance in deficit reduction between revenue and cuts, and between non-defense cuts and defense cuts, to invest in job creation, and for other purposes.

H.R. 500, Alan Grayson, to amend title XVIII of the Social Security Act to provide for an option for any citizen or permanent resident of the United States to buy into Medicare.

H.R. 487, Cathy McMorris Rodgers, to provide for a Medicare primary care graduate medical education pilot project in order to improve access to the primary care workforce.

H.R. 486, William Keating, to amend the Federal Food, Drug, and Cosmetic Act to incentivize the development of abuse-deterrent drugs

H.R. 485, Eddie Bernice Johnson, to establish the position of National Nurse for Public Health, to be filled by the same individual serving as the Chief Nurse Officer of the Public Health Service.

H.R. 475, Jim Gerlach, to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines.

H.R. 473, Gerald Connolly, to amend titles XVIII and XIX of the Social Security Act with respect to the qualification of the director of food services of a Medicare skilled nursing facility or a Medicaid nursing facility.

H.R. 467, Gerald Connolly, to amend title XIX of the Social Security Act to redistribute Federal funds that would otherwise be made available to States that do not provide for the Medicaid expansion in accordance with the Affordable Care Act to those States electing to provide those Medicaid benefits.

H.R. 466, Michael Capuano, to amend title II of the Social Security Act to prohibit the Commissioner of Social Security from publishing the social security numbers of deceased individuals in the Death Master File, and for other purposes.

H.R. 460, David McKinley, to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes.

 

This entry was posted in On The Hill and tagged , . Bookmark the permalink.

Comments are closed.